All,
Several folks have pointed out that the ranking instructions are not clear.
Please use the average ranking (of your top 6 scores)), on the BOF website:
David McCann (6821, 1137 ave) and above should run A course.
Hazel Hindle (6068, 1011 average) run either of B1 or B2 (or A).
And so on.
Attached are details of the closed MDOC/DEE challenge and ‘pilot’ Alderley Park event
Location using Google Maps:
https://www.google.com/maps/place/Congleton+Rd,+Macclesfield,+Cheshire+East+SK10+4TD,+UK/@53.2671786,-2.2352917,17z/data=!3m1!4b1!4m2!3m1!1s0x487a4e333aeced4b:0x3695a9706c1bc049
StreetMap location:
http://www.streetmap.co.uk/map.srf?x=384471&y=374584&z=120&sv=384471,374584&st=4&ar=y&mapp=map.srf&searchp=ids.srf&dn=655&ax=384471&ay=374584&lm=0
Re courses B1 and B2 and C1 and C2, you can choose depending on whether you prefer sprint or urban ‘O’!
Also, anyone who is unranked (e.g. Juniors) can choose whichever course they wish to run.
Any other queries let me know.
This will be a minimalist and ‘just-in-time’ event!
Mike
From:
mdoc-manager@simplelists.com [mailto:mdoc-manager@simplelists.com]
On Behalf Of (via mdoc list)
Sent: 19 March 2015 13:09
To: mdoc@simplelists.com
Subject: [MDOC] MDOC DEE Challenge 2015
|
This email was sent from aol.com which does not allow forwarding of emails via email lists. Therefore the sender's email address (mccannhg@aol.com) has been replaced with a dummy one. |
Dear All,
Having been soundly walloped by DEE last year, I have issued a challenge to DEE to come and try to repeat the performance on our home ground, if they dare!
Please let me know if you are interested.
Dave McCann
AstraZeneca UK Limited is a company incorporated in England and Wales with registered number: 03674842 and a registered office at 2 Kingdom Street, London, W2 6BD.
Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful.
Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email.
Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking compliance with our Code of Conduct and policies.